Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Bicalutamide may help treat female pattern hair loss.

Finasteride may improve prostate cancer treatment outcomes.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Many drugs can cause temporary hair loss, which usually stops when the drug is discontinued.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Topical finasteride may help treat facial hirsutism in women.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Mutations in certain receptors can cause diseases and offer new treatment options.

New compounds show promise as nonsteroidal treatments for hair loss.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.